Phan Q, Solis N, Cravener M, Swidergall M, Lin J, Huang M, et al. Candida albicans stimulates the formation of a multi-receptor complex that mediates epithelial cell invasion during oropharyngeal infection. bioRxiv. 2023;: pubmed publisher

Altintas D, Gallo S, Basilico C, Cerqua M, Bocedi A, Vitacolonna A, et al. The PSI Domain of the MET Oncogene Encodes a Functional Disulfide Isomerase Essential for the Maturation of the Receptor Precursor. Int J Mol Sci. 2022;23: pubmed publisher

Xie X, Shirasu T, Guo L, Kent K. Smad2 inhibition of MET transcription potentiates human vascular smooth muscle cell apoptosis. Atheroscler Plus. 2021;44:31-42 pubmed publisher

Mancini M, Thomas Q, Bourdel S, Papon L, Bousquet E, Jalta P, et al. Generation and Characterization of a New Preclinical Mouse Model of EGFR-Driven Lung Cancer with MET-Induced Osimertinib Resistance. Cancers (Basel). 2021;13: pubmed publisher

Krenzlin H, Zdioruk M, Nowicki M, Finkelberg T, Keric N, Lemmermann N, et al. Cytomegalovirus infection of glioblastoma cells leads to NF-κB dependent upregulation of the c-MET oncogenic tyrosine kinase. Cancer Lett. 2021;513:26-35 pubmed publisher

Torrino S, Tiroille V, Dolfi B, Dufies M, Hinault C, Bonesso L, et al. UBTD1 regulates ceramide balance and endolysosomal positioning to coordinate EGFR signaling. elife. 2021;10: pubmed publisher

Baschieri F, Le Devedec D, Tettarasar S, Elkhatib N, Montagnac G. Frustration of endocytosis potentiates compression-induced receptor signaling. J Cell Sci. 2020;133: pubmed publisher

Parsons B, Meier D, Richmond C, Gurda G, Lofgren K, Burkard M, et al. Acquisition of Cabozantinib-Sensitive MET D1228N Mutation During Progression on Crizotinib in MET-Amplified Triple-Negative Breast Cancer. Clin Breast Cancer. 2020;: pubmed publisher

Xie Y, Nurkesh A, Ibragimova N, Zhanzak Z, Meyerbekova A, Alexeyeva Z, et al. Systematic analysis of NLMP suggests nuclear localization of RTK/MET kinases resemble cancer cell clearance. J Exp Clin Cancer Res. 2019;38:43 pubmed publisher

Baschieri F, Dayot S, Elkhatib N, Ly N, Capmany A, Schauer K, et al. Frustrated endocytosis controls contractility-independent mechanotransduction at clathrin-coated structures. Nat Commun. 2018;9:3825 pubmed publisher

Ardelt M, Frohlich T, Martini E, Muller M, Kanitz V, Atzberger C, et al. Inhibition of Cyclin-Dependent Kinase 5: A Strategy to Improve Sorafenib Response in Hepatocellular Carcinoma Therapy. Hepatology. 2019;69:376-393 pubmed publisher

Sa J, Kim S, Lee J, Cho H, Shin Y, Shin H, et al. Identification of genomic and molecular traits that present therapeutic vulnerability to HGF-targeted therapy in glioblastoma. Neuro Oncol. 2019;21:222-233 pubmed publisher

Kim S, Kim H, Yun M, Kang H, Pyo K, Park H, et al. Activation of the Met kinase confers acquired drug resistance in FGFR-targeted lung cancer therapy. Oncogenesis. 2016;5:e241 pubmed publisher

Coleman D, Gray A, Kridel S, Cardelli J. Palmitoylation regulates the intracellular trafficking and stability of c-Met. Oncotarget. 2016;7:32664-77 pubmed publisher